87 related articles for article (PubMed ID: 7543572)
41. Effects of short- and long-term haloperidol administration and withdrawal on regional brain cholecystokinin and neurotensin concentrations in the rat.
Radke JM; MacLennan AJ; Beinfeld MC; Bissette G; Nemeroff CB; Vincent SR; Fibiger HC
Brain Res; 1989 Feb; 480(1-2):178-83. PubMed ID: 2713650
[TBL] [Abstract][Full Text] [Related]
42. Specificity of neurotensin metabolism by regional rat brain slices.
Davis TP; Gillespie TJ; Konings PN
J Neurochem; 1992 Feb; 58(2):608-17. PubMed ID: 1729405
[TBL] [Abstract][Full Text] [Related]
43. Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortex.
Taquet H; Javoy-Agid F; Mauborgne A; Benoliel JJ; Agid Y; Legrand JC; Tramu G; Cesselin F; Hamon M
Neuroscience; 1988 Dec; 27(3):871-83. PubMed ID: 2472575
[TBL] [Abstract][Full Text] [Related]
44. Neuropeptide influences on the development of their receptors.
Handelmann GE
Prog Brain Res; 1988; 73():523-33. PubMed ID: 2458616
[No Abstract] [Full Text] [Related]
45. Correlation of neurochemical and behavioral effects of triethyl lead chloride in rats.
Hong JS; Tilson HA; Hudson P; Ali SF; Wilson WE; Hunter V
Toxicol Appl Pharmacol; 1983 Jul; 69(3):471-9. PubMed ID: 6192548
[TBL] [Abstract][Full Text] [Related]
46. Changes in methionine-enkephalin levels in specific rat brain regions following repeated treatment with selective dopaminergic agonists and antagonists.
Elwan MA; Soliman MR
Life Sci; 1996; 58(1):37-45. PubMed ID: 8628109
[TBL] [Abstract][Full Text] [Related]
47. Substance P involved in mental disorders.
Takeuchi K; Uematsu M; Ofuji M; Morikiyo M; Kaiya H
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12 Suppl():S157-64. PubMed ID: 2471228
[TBL] [Abstract][Full Text] [Related]
48. The effect of haloperidol on met-enkephalin, beta-endorphin, cholecystokinin and substance P in the pituitary, the hypothalamus and the striatum of rats during aging.
Lau SM; Tang F
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1163-75. PubMed ID: 8787040
[TBL] [Abstract][Full Text] [Related]
49. [The immune response evokes changes of substance P content in some brain areas].
Zhu G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Dec; 15(6):417-21. PubMed ID: 7521801
[TBL] [Abstract][Full Text] [Related]
50. Degradation of met-enkephalin by extracts of various regions of the human brain: effects of antipsychotics and narcotics in vitro.
Jakubovic A
Peptides; 1982; 3(1):21-6. PubMed ID: 6123112
[TBL] [Abstract][Full Text] [Related]
51. Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices.
Rose C; Camus A; Schwartz JC
Neuroscience; 1989; 29(3):583-94. PubMed ID: 2739903
[TBL] [Abstract][Full Text] [Related]
52. Chronic dietary treatment with antidepressants decrease brain Met-enkephalin-like immunoreactivity in the rat.
Kurumaji A; Mitsushio H; Takashima M
Psychopharmacology (Berl); 1988; 94(2):188-92. PubMed ID: 3127844
[TBL] [Abstract][Full Text] [Related]
53. Possible involvement of proteases in the regulation of spermatogenesis.
Monsees TK; Görnig M; Schill WB; Miska W
Andrologia; 1998; 30(4-5):185-91. PubMed ID: 9739415
[TBL] [Abstract][Full Text] [Related]
54. Long-lasting neurochemical and functional changes in rats induced by neonatal administration of substance P antiserum.
De Felipe MC; Molinero MT; Del Río J
Brain Res; 1989 Apr; 485(2):301-8. PubMed ID: 2470472
[TBL] [Abstract][Full Text] [Related]
55. Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease.
Waters SM; David TP
J Gerontol A Biol Sci Med Sci; 1995 Sep; 50(5):B315-9. PubMed ID: 7545530
[TBL] [Abstract][Full Text] [Related]
56. Changes in brain enkephalin immunostaining after acute carbon disulfide exposure in rats.
de Gandarias JM; Echevarría E; Múgica J; Serrano R; Casis L
J Biochem Toxicol; 1994 Apr; 9(2):59-62. PubMed ID: 8071946
[TBL] [Abstract][Full Text] [Related]
57. Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slices.
Camus A; Rose C; Schwartz JC
Neuroscience; 1989; 29(3):595-602. PubMed ID: 2662053
[TBL] [Abstract][Full Text] [Related]
58. Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type.
Waters SM; Davis TP
Ann N Y Acad Sci; 1997 Apr; 814():30-9. PubMed ID: 9160957
[TBL] [Abstract][Full Text] [Related]
59. Neuropeptides in human brain--postmortem studies.
Kleinman JE; Hong J; Iadarola M; Govoni S; Gillin CJ
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):91-5. PubMed ID: 2581284
[TBL] [Abstract][Full Text] [Related]
60. Effect of subacute toluene administration on the enkephalinergic neuromodulatory system in rats and protective action of ganglioside treatments.
De Gandarias JM; Echevarria E; Serrano R; Irazusta J; Casis L
Toxicol Ind Health; 1994; 10(3):155-61. PubMed ID: 7855865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
